Zobrazeno 1 - 10
of 32 807
pro vyhledávání: ''
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:871-881
Background: Colorectal cancer (CRC) is the third most common malignancy worldwide. Matrine can act as a potential antitumor drug, and its antitumor activities have been tested in various cancers, including CRC. However, the effect of matrine and the
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:650-661
Background: Breast cancer is one of the most prevalent cancers that often occur in females. Long noncoding RNA differentiation antagonizing nonprotein coding RNA (DANCR) has been involved in the pathogenesis of various tumors, including breast cancer
Publikováno v:
Seminars in Cancer Biology. 83:261-268
Thyroid cancer is not among the top cancers in terms of diagnosis or mortality but it still ranks fifth among the cancers diagnosed in women. Infact, women are more likely to be diagnosed with thyroid cancer than the males. The burden of thyroid canc
Autor:
Elena Lukina, Mario Menschikowski, Albert Hagelgans, Gjumrakch Aliev, Markus Friedemann, Olga A. Sukocheva
Publikováno v:
Seminars in Cancer Biology. 82:35-59
Breast cancer (BC) cell de-sensitization to Tamoxifen (TAM) or other selective estrogen receptor (ER) modulators (SERM) is a complex process associated with BC heterogeneity and the transformation of ER signalling. The most influential resistance-rel
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:246-255
Background: Pituitary adenoma (PA) is a kind of common primary brain tumor with invasive properties. Although the fact that long noncoding RNA (lncRNA) small nucleolar RNA host gene 6 (SNHG6) exerts oncogenic function in cancer cells and that miR-944
Publikováno v:
Cancer Biomarkers. 34:13-22
BACKGROUND: PPM1G, a member of the serine/threonine protease family, dephosphorylates various proteins and may be involved in cancer development. The role and mechanism of PPM1G in HCC still needs to be verified. OBJECTIVE: This study aims to explore
Publikováno v:
FEBS Open Bio. 12:983-992
Colorectal cancer (CRC) is the third main cause of cancer-relevant deaths worldwide, and its incidence has increased in recent decades. Previous studies have indicated that certain long noncoding RNAs (lncRNAs) have regulatory roles in tumor occurren
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:119-124
LncRNA ELF3-AS1 has been characterized as an oncogenic lncRNA in bladder cancer and oral cancer, whereas its role in non-small cell lung cancer (NSCLC) is unknown. In this study, the authors observed that ELF3-AS1 was upregulated in NSCLC tissues in
Autor:
Hua-Fu Zhou, Jiao Luo, Jie Yang, Lin-Jie Yang, Gang Chen, Da-Ping Yang, Yi-Fan Jiang, Lin Shi, Wei-Jia Mo, Shu-Ping Huang, Mei-Ting Liang, Ting-Qing Gan
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:125-140
Background: To explore the clinical significance of miR-125b-5p and its potential mechanisms in lung squamous cell carcinoma (LUSC). Materials and Methods: An integrated analysis of data from in-house quantitative real-time polymerase chain reaction
Autor:
Amirhoushang Poorkhani, Solmaz Khalighfard, Mohammad Reza Kalhori, Ebrahim Esmati, Marzieh Lashkari, Vahid Khori, Taghi Amiriani, Ali Mohammad Alizadeh, Ali Najafi
Publikováno v:
Cancer Biomarkers. 33:97-110
BACKGROUND: The discovery of miRNA/mRNA interactions in several biological samples prompted the researchers to explore new biomarkers in tumors. OBJECTIVE: We aimed to investigate the interactions of miRNA/mRNA in response to radiotherapy in the plas